219 related articles for article (PubMed ID: 31964505)
1. Genome based safety assessment for Bacillus coagulans strain LBSC (DSM 17654) for probiotic application.
Saroj DB; Gupta AK
Int J Food Microbiol; 2020 Apr; 318():108523. PubMed ID: 31964505
[TBL] [Abstract][Full Text] [Related]
2. Integrate genome-based assessment of safety for probiotic strains: Bacillus coagulans GBI-30, 6086 as a case study.
Salvetti E; Orrù L; Capozzi V; Martina A; Lamontanara A; Keller D; Cash H; Felis GE; Cattivelli L; Torriani S; Spano G
Appl Microbiol Biotechnol; 2016 May; 100(10):4595-605. PubMed ID: 26952108
[TBL] [Abstract][Full Text] [Related]
3. In-silico analysis of probiotic attributes and safety assessment of probiotic strain Bacillus coagulans BCP92 for human application.
Shaikh SS; Jhala D; Patel A; Chettiar SS; Ghelani A; Malik A; Sengupta P
Lett Appl Microbiol; 2024 Jan; 77(1):. PubMed ID: 38148133
[TBL] [Abstract][Full Text] [Related]
4. Genomic-, phenotypic-, and toxicity-based safety assessment and probiotic potency of Bacillus coagulans IDCC 1201 isolated from green malt.
Bang WY; Ban OH; Lee BS; Oh S; Park C; Park MK; Jung SK; Yang J; Jung YH
J Ind Microbiol Biotechnol; 2021 Jul; 48(5-6):. PubMed ID: 33904924
[TBL] [Abstract][Full Text] [Related]
5. Complete genome sequence of probiotic Bacillus coagulans HM-08: A potential lactic acid producer.
Yao G; Gao P; Zhang W
J Biotechnol; 2016 Jun; 228():71-72. PubMed ID: 27130497
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of genetic and phenotypic consistency of Bacillus coagulans MTCC 5856: a commercial probiotic strain.
Majeed M; Nagabhushanam K; Natarajan S; Sivakumar A; Eshuis-de Ruiter T; Booij-Veurink J; de Vries YP; Ali F
World J Microbiol Biotechnol; 2016 Apr; 32(4):60. PubMed ID: 26925622
[TBL] [Abstract][Full Text] [Related]
7. Functional annotation of the genome unravels probiotic potential of Bacillus coagulans HS243.
Kapse NG; Engineer AS; Gowdaman V; Wagh S; Dhakephalkar PK
Genomics; 2019 Jul; 111(4):921-929. PubMed ID: 29859262
[TBL] [Abstract][Full Text] [Related]
8. Genetic and phenotypic assessments for the safety of probiotic
Saroj DB; Ahire JJ; Shukla R
3 Biotech; 2023 Jul; 13(7):238. PubMed ID: 37333714
[TBL] [Abstract][Full Text] [Related]
9. Impact of a Gastrointestinal Stable Probiotic Supplement
Maity C; Gupta PhD AK; Saroj DB; Biyani A; Bagkar P; Kulkarni J; Dixit Y
J Diet Suppl; 2021; 18(6):577-596. PubMed ID: 32896190
[No Abstract] [Full Text] [Related]
10. Probiotic Potential and Safety Assessment of
Liu B; Zhong X; Liu Z; Guan X; Wang Q; Qi R; Zhou X; Huang J
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139398
[TBL] [Abstract][Full Text] [Related]
11. A prospective, interventional, randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of Bacillus coagulans LBSC in the treatment of acute diarrhea with abdominal discomfort.
Maity C; Gupta AK
Eur J Clin Pharmacol; 2019 Jan; 75(1):21-31. PubMed ID: 30264164
[TBL] [Abstract][Full Text] [Related]
12. Genomic and Phenotypic Safety Assessment of Probiotic Bacillus coagulans Strain JBI-YZ6.3.
Zhang Y; Overbeck TJ; Skebba VLP; Gandhi NN
Probiotics Antimicrob Proteins; 2024 Jun; ():. PubMed ID: 38896222
[TBL] [Abstract][Full Text] [Related]
13. Complete Genomes of Bacillus coagulans S-lac and Bacillus subtilis TO-A JPC, Two Phylogenetically Distinct Probiotics.
Khatri I; Sharma S; Ramya TN; Subramanian S
PLoS One; 2016; 11(6):e0156745. PubMed ID: 27258038
[TBL] [Abstract][Full Text] [Related]
14. The metabolism and morphology mutation response of probiotic Bacillus coagulans for lead stress.
Xing SC; Mi JD; Chen JY; Xiao L; Wu YB; Liang JB; Zhang LH; Liao XD
Sci Total Environ; 2019 Nov; 693():133490. PubMed ID: 31635006
[TBL] [Abstract][Full Text] [Related]
15. Complete Genome Sequencing Revealed the Potential Application of a Novel
Wang Y; Gu Z; Zhang S; Li P
Foods; 2023 Jan; 12(1):. PubMed ID: 36613432
[No Abstract] [Full Text] [Related]
16. Identification and Antimicrobial Resistance of Bacteria Isolated from Probiotic Products Used in Shrimp Culture.
Noor Uddin GM; Larsen MH; Christensen H; Aarestrup FM; Phu TM; Dalsgaard A
PLoS One; 2015; 10(7):e0132338. PubMed ID: 26147573
[TBL] [Abstract][Full Text] [Related]
17. Bacillus coagulans SANK 70258 suppresses Enterobacteriaceae in the microbiota of ulcerative colitis in vitro and enhances butyrogenesis in healthy microbiota.
Sasaki K; Sasaki D; Inoue J; Hoshi N; Maeda T; Yamada R; Kondo A
Appl Microbiol Biotechnol; 2020 May; 104(9):3859-3867. PubMed ID: 32146494
[TBL] [Abstract][Full Text] [Related]
18. Safety assessment of the butyrate-producing Butyricicoccus pullicaecorum strain 25-3(T), a potential probiotic for patients with inflammatory bowel disease, based on oral toxicity tests and whole genome sequencing.
Steppe M; Van Nieuwerburgh F; Vercauteren G; Boyen F; Eeckhaut V; Deforce D; Haesebrouck F; Ducatelle R; Van Immerseel F
Food Chem Toxicol; 2014 Oct; 72():129-37. PubMed ID: 25007784
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of Genome-Wide Screening for Biosafety Assessment of Probiotics: A Case Study of Lactobacillus helveticus MTCC 5463.
Senan S; Prajapati JB; Joshi CG
Probiotics Antimicrob Proteins; 2015 Dec; 7(4):249-58. PubMed ID: 26223907
[TBL] [Abstract][Full Text] [Related]
20. Complete genome sequence and bioinformatics analyses of Bacillus thuringiensis strain BM-BT15426.
Liu J; Li L; Peters BM; Li B; Chen D; Xu Z; Shirtliff ME
Microb Pathog; 2017 Jul; 108():55-60. PubMed ID: 28479507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
